Want to see TECX full AI Analyst Report?
Total Valuation
Tectonic Therapeutic has a market cap or net worth of $403.69M. The enterprise value is $429.22M.
Market Cap$403.69M
Enterprise Value$429.22M
Share Statistics
Tectonic Therapeutic has 19,549,366 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding19,549,366
Owned by Insiders34.38%
Owned by Institutions29.81%
Financial Efficiency
Tectonic Therapeutic’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -33.27%.
Return on Equity (ROE)-0.30
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-33.27%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee0.00
Profits Per Employee-1.24M
Employee Count60
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tectonic Therapeutic is ―. Tectonic Therapeutic’s PEG ratio is -1.69.
PE Ratio―
PS Ratio0.00
PB Ratio1.52
Price to FCF-6.34
Price to Operating Cash Flow-5.43
PEG Ratio-1.69
Income Statement
In the last 12 months, Tectonic Therapeutic had revenue of 0.00 and earned -74.15M in profits. Earnings per share was -4.05.
Revenue0.00
Gross Profit0.00
Operating Income-84.04M
Pretax Income-72.92M
Net Income-74.15M
EBITDA-71.48M
Earnings Per Share (EPS)-4.05
Cash Flow
In the last 12 months, operating cash flow was -72.14M and capital expenditures -306.00K, giving a free cash flow of -72.45M billion.
Operating Cash Flow-72.14M
Free Cash Flow-72.45M
Free Cash Flow per Share-3.71
Dividends & Yields
Tectonic Therapeutic pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.34
52-Week Price Change8.40%
50-Day Moving Average28.76
200-Day Moving Average28.07
Relative Strength Index (RSI)27.00
Average Volume (3m)220.00K
Important Dates
Tectonic Therapeutic upcoming earnings date is Nov 5, 2026, TBA (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Tectonic Therapeutic as a current ratio of 26.63, with Debt / Equity ratio of 1.97%
Current Ratio26.63
Quick Ratio26.63
Debt to Market Cap<0.01
Net Debt to EBITDA3.53
Interest Coverage Ratio-1.33K
Taxes
In the past 12 months, Tectonic Therapeutic has paid 1.23M in taxes.
Income Tax1.23M
Effective Tax Rate-0.02
Enterprise Valuation
Tectonic Therapeutic EV to EBITDA ratio is -1.81, with an EV/FCF ratio of -2.15.
EV to Sales0.00
EV to EBITDA-1.81
EV to Free Cash Flow-2.15
EV to Operating Cash Flow-2.16
Balance Sheet
Tectonic Therapeutic has $227.07M in cash and marketable securities with $4.40M in debt, giving a net cash position of $222.67M billion.
Cash & Marketable Securities$227.07M
Total Debt$4.40M
Net Cash$222.67M
Net Cash Per Share$11.39
Tangible Book Value Per Share$13.72
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tectonic Therapeutic is $69.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$69.75
Price Target Upside84.96% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast―
EPS Growth Forecast-13.09%